INHIBITION OF PLATELET ACTIVATION BY THE NOVEL THROMBOXANE RECEPTOR ANTAGONIST BM 13.505

被引：0

作者：

PATSCHEKE, H

STEGMEIER, K

HORNBERGER, W

STAIGER, C

NEUGEBAUER, G

机构：

[1] UNIV HEIDELBERG,KLINIKUM MANNHEIM,INST CLIN CHEM,D-6800 MANNHEIM 1,FED REP GER

[2] BOEHRINGER MANNHEIM GMBH,DEPT MED RES,D-6800 MANNHEIM 31,FED REP GER

来源：

THROMBOSIS AND HAEMOSTASIS | 1987年 / 58卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：182 / 182

页数：1

共 50 条

[1] BENEFICIAL-EFFECTS OF A THROMBOXANE RECEPTOR ANTAGONIST (BM-13.505) ON PLATELET HYPERREACTIVITY AND THROMBOXANE FORMATION IN CHOLESTEROL-FED RABBITS
LOBEL, P
SCHROR, E
SCHROR, K
BIOMEDICA BIOCHIMICA ACTA, 1988, 47 (10-11) : S86 - S89
[2] EFFECTS OF THE THROMBOXANE RECEPTOR ANTAGONIST, BM-13.505, ON THE SEQUELAE OF ENDOTOXEMIA IN THE CONSCIOUS RAT
KINTER, LB
JUGUS, M
SMITH, EF
CIRCULATORY SHOCK, 1988, 24 (04) : 237 - 237
[3] INHIBITION OF PLATELET-FUNCTION BY A SELECTIVE THROMBOXANE ANTAGONIST (BM 13.177)
PATSCHEKE, H
STEGMEIER, K
BLUT, 1984, 49 (02): : 156 - 156
[4] COMPARISON OF THE INHIBITORY ACTIVITY OF FREE AND ALBUMIN BOUND THROMBOXANE RECEPTOR ANTAGONIST BM13.505 ON U46619 INDUCED PLATELET-AGGREGATION
KLIMM, JL
KLOCZEWIAK, M
LINDON, JN
THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 191 - 191
[5] THE NEW THROMBOXANE RECEPTOR ANTAGONIST BM 13.505 PROTECTS RABBITS AGAINST GLYCEROL-INDUCED RENAL-FAILURE
STEGMEIER, K
HARTIG, F
PILL, J
PATSCHEKE, H
THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 126 - 126
[6] EFFECTS OF THE THROMBOXANE RECEPTOR ANTAGONIST BM13.505 ON RENAL-FUNCTION IN BILE-DUCT LIGATED RATS
LIU, T
WAIT, RB
KAHNG, KU
GASTROENTEROLOGY, 1995, 108 (04) : A1111 - A1111
[7] BM-13.505, A SELECTIVE THROMBOXANE RECEPTOR ANTAGONIST, REDUCES MYOCARDIAL INFARCT SIZE FOLLOWING CORONARY-ARTERY REPERFUSION
SMITH, EF
EARL, CQ
EGAN, JW
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 38 (01): : 15 - 23
[8] EFFECTS OF THROMBOXANE RECEPTOR BLOCKER BM 13.505 ON THE DEVELOPMENT OF PROTEINURIA IN AUTOIMMUNE NZB/W MICE
STEGMEIER, K
MERTIN, J
PILL, J
HARTIG, F
THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 262 - 262
[9] REDUCTION OF MYOCARDIAL DAMAGE AND POLYMORPHONUCLEAR LEUKOCYTE ACCUMULATION FOLLOWING CORONARY-ARTERY OCCLUSION AND REPERFUSION BY THE THROMBOXANE RECEPTOR ANTAGONIST BM 13.505
SMITH, EF
GRISWOLD, DE
EGAN, JW
HILLEGASS, LM
DIMARTINO, MJ
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 (05) : 715 - 772
[10] Activity of a novel dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles
Rolin, S
Dogné, JM
Michaux, C
Delarge, J
Masereel, B
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2001, 65 (02): : 67 - 72

← 1 2 3 4 5 →